This startup develops AI-driven digital therapies and biomarkers for musculoskeletal and chronic pain disorders. Their platform provides patients with tools for self-management and aims to improve therapeutic outcomes and the quality of care.
Funding
Funding not disclosed
Founders
Product
Problem
Managing inflammatory arthritis, such as rheumatoid or psoriatic arthritis, presents challenges due to unpredictable flare-ups and the limitations of infrequent, in-clinic monitoring. Healthcare providers often lack the resources for continuous, objective patient monitoring, hindering timely interventions and effective management of chronic conditions.
Solution
ATREON's DETECTRA is a remote monitoring system for inflammatory arthritis, providing convenient access to patient health trends from home. The system includes a mobile app for patients to capture hand images and report outcomes, and a web-based dashboard for healthcare providers to visualize this data. DETECTRA uses image-recognition technology to track indicators like the Finger Fold Index (FFI), observing changes in joint appearance, mobility, and stiffness over time. The platform helps organize patient information, enabling healthcare providers to optimize follow-up, visit planning, and overall patient management.
Target Audience
The primary users are healthcare providers, specifically those managing patients with inflammatory arthritis, such as rheumatologists and general practitioners.
Features
- Mobile app (iOS and Android) for patients to report outcomes and capture hand images
- Web-based dashboard for healthcare providers to visualize patient-reported data and images
- Image-recognition technology to track indicators like the Finger Fold Index (FFI)
- Smart notifications to help healthcare providers prioritize follow-up
- Customizable tracking based on patient needs
- Developing digital biomarkers that offer additional insights